English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 18 April 2019, 20:00 HKT/SGT
Share:
    

Source: ReShape Lifesciences Inc.
ReShape Lifesciences Announces Distribution in Australia

SAN CLEMENTE, CA & MELBOURNE, AU, Apr 18, 2019 - (ACN Newswire) - ReShape Lifesciences™, a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announces that as of April 1, 2019, the company was selling its LAP-BAND® product in the Australian market through a relationship with Satori Healthcare. Satori Healthcare is a medical device distributor focused on the Australian bariatric market.

The founder of Satori Healthcare has over 20 years of experience in the medical device industry, including 6 years of direct responsibility for LAP-BAND while it was owned by Allergan and Apollo Endosurgery respectively. Concurrent with this relationship, ReShape Lifesciences has fully taken over all distribution of the LAP-BAND product in Australia from Apollo Endosurgery, Inc. and will subsequently be recognizing revenue from sales of the product in Australia.

Over 120,000 LAP-BAND procedures have taken place in Australia since the product was launched in the country, making Australia one of the largest worldwide markets for LAP-BAND outside of the U.S. Australia was one of the early adopters of the LAP-BAND technology and has produced some of the strongest data and research on the product. According to the OECD 2017 Obesity Update, based on self-reported data, 27.9% of the Australian adult population are obese, the fifth highest obesity rate of any developed country.

About ReShape Lifesciences Inc

ReShape Lifesciences™ (OTCQB: RSLS) is a medical device company focused on technologies to treat obesity and metabolic diseases. The FDA-approved LAP-BAND® Adjustable Gastric Banding System is designed to provide minimally invasive long-term treatment of severe obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It is intended to enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.

Investor Contact:
Scott Youngstrom
Chief Financial Officer
ReShape Lifesciences Inc.
+1-949-429-6680 x106
[email protected]

SOURCE: ReShape Lifesciences Inc.

Topic: Press release summary
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Billionaire Mai Vu Minh welcomed the assistant of Bosnia-Herzegovina President to pay an official visit to Vietnam  
Feb 24, 2020 21:00 HKT/SGT
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong  
Feb 24, 2020 20:13 HKT/SGT
NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress  
Feb 24, 2020 19:15 HKT/SGT
ERB Secures $1 Billion Investment from McKinley Investment; Reimagines Global Financial Markets and Investor Risk in Southeast Asia  
Feb 24, 2020 16:40 HKT/SGT
Davis Index launches world's only Market Price Platform built for Metals Recycling Industry  
Feb 24, 2020 12:10 HKT/SGT
VPower Group Signs New Contract Aggregating a Total Installed Capacity of Close to 100MW in Sri Lanka  
Feb 24, 2020 09:05 HKT/SGT
Viva Biotech Included as Constituent Stock of Hang Seng Composite Index and Other 6 Indexes, Becoming an Eligible Stock of Shenzhen-Hong Kong Stock Connect  
Feb 24, 2020 07:32 HKT/SGT
COMM's New Project Launch Integrates Publisher and Hedge Funds on Blockchain  
Feb 23, 2020 17:00 HKT/SGT
The Closure of Automobile Production in the Philippines  
Feb 22, 2020 17:00 HKT/SGT
Uniting Hong Kong People to Fight the Coronavirus, Chun Wo Charitable Foundation Donates over 200,000 Surgical Masks and HK$400,000  
Feb 21, 2020 17:37 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575